Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA LUPIN BAL PHARMA/
LUPIN
 
P/E (TTM) x 40.8 40.7 100.3% View Chart
P/BV x 2.3 6.0 37.8% View Chart
Dividend Yield % 1.1 0.2 443.2%  

Financials

 BAL PHARMA   LUPIN
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
LUPIN
Mar-23
BAL PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs134799 16.8%   
Low Rs63583 10.9%   
Sales per share (Unadj.) Rs193.9365.8 53.0%  
Earnings per share (Unadj.) Rs1.79.8 17.0%  
Cash flow per share (Unadj.) Rs7.529.2 25.6%  
Dividends per share (Unadj.) Rs1.004.00 25.0%  
Avg Dividend yield %1.00.6 174.9%  
Book value per share (Unadj.) Rs40.7270.7 15.0%  
Shares outstanding (eoy) m15.69454.98 3.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.9 27.0%   
Avg P/E ratio x59.270.2 84.2%  
P/CF ratio (eoy) x13.223.7 55.7%  
Price / Book Value ratio x2.42.6 95.2%  
Dividend payout %59.940.7 147.4%   
Avg Mkt Cap Rs m1,549314,381 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m55330,872 1.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,042166,417 1.8%  
Other income Rs m91,509 0.6%   
Total revenues Rs m3,052167,926 1.8%   
Gross profit Rs m25317,206 1.5%  
Depreciation Rs m918,807 1.0%   
Interest Rs m1232,743 4.5%   
Profit before tax Rs m477,165 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m212,688 0.8%   
Profit after tax Rs m264,477 0.6%  
Gross profit margin %8.310.3 80.3%  
Effective tax rate %44.837.5 119.5%   
Net profit margin %0.92.7 32.0%  
BALANCE SHEET DATA
Current assets Rs m2,282124,513 1.8%   
Current liabilities Rs m2,09392,654 2.3%   
Net working cap to sales %6.219.1 32.3%  
Current ratio x1.11.3 81.1%  
Inventory Days Days826 29.2%  
Debtors Days Days1,12898 1,147.3%  
Net fixed assets Rs m829103,490 0.8%   
Share capital Rs m157910 17.2%   
"Free" reserves Rs m481122,246 0.4%   
Net worth Rs m638123,156 0.5%   
Long term debt Rs m305275 111.0%   
Total assets Rs m3,110228,003 1.4%  
Interest coverage x1.43.6 38.4%   
Debt to equity ratio x0.50 21,421.3%  
Sales to assets ratio x1.00.7 134.0%   
Return on assets %4.83.2 151.6%  
Return on equity %4.13.6 113.0%  
Return on capital %18.18.0 225.4%  
Exports to sales %66.40-   
Imports to sales %22.40-   
Exports (fob) Rs m2,020NA-   
Imports (cif) Rs m683NA-   
Fx inflow Rs m2,02048,057 4.2%   
Fx outflow Rs m71621,752 3.3%   
Net fx Rs m1,30526,306 5.0%   
CASH FLOW
From Operations Rs m-1818,972 -0.1%  
From Investments Rs m-222-12,868 1.7%  
From Financial Activity Rs m244-3,373 -7.2%  
Net Cashflow Rs m42,732 0.1%  

Share Holding

Indian Promoters % 47.1 46.8 100.7%  
Foreign collaborators % 4.2 0.3 1,482.1%  
Indian inst/Mut Fund % 0.1 45.8 0.3%  
FIIs % 0.1 16.1 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 53.0 92.1%  
Shareholders   15,060 281,542 5.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs Lupin Share Price Performance

Period BAL PHARMA Lupin S&P BSE HEALTHCARE
1-Day -4.40% 1.23% 1.18%
1-Month -17.76% 0.15% -0.75%
1-Year 40.93% 151.14% 61.82%
3-Year CAGR 19.04% 17.13% 18.16%
5-Year CAGR 5.43% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.